Hospitals Decry Genentech's Cancer Drug Delivery Overhaul

By Erica Teichert · October 29, 2014, 7:33 PM EDT

Six hospital associations called on Genentech Inc. on Monday to nix its decision to solely promulgate three cancer drugs via specialty distributors rather than traditional wholesale providers, saying the "misguided" plan...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Letter

Recent Articles By Erica

November 20, 2014
Health Care MVP: King & Spalding's Michael Paulhus
November 14, 2014
ACA Contraception Exemption Isn't Burdensome: DC Circ.
November 10, 2014
HHS Issues Special HIPAA Bulletin On Ebola Privacy
November 06, 2014
Expect Another House Vote To Repeal ACA, Boehner Says
October 28, 2014
Daschle Leaves DLA Piper For Baker Donelson Policy Group
October 27, 2014
CDC Issues Ebola Monitoring Guidelines Amid Quarantines
October 07, 2014
2nd Circ. Revives Portion Of NY Medicaid Payment Row
October 02, 2014
High Court To Review Medicaid Providers' Right To Sue States
September 30, 2014
Okla. Judge Rejects ACA Tax Subsidies On Federal Exchanges
September 26, 2014
Ala. Hospital Can't Escape Data Breach Class Action